Search

everythinglearnresearchcommunity

for

Search:↓

A new system helps better diagnose and treat female androgenization conditions like PCOS.

Researchers found a new ABCD1 gene mutation linked to a rare brain and nerve disorder with unusual brain changes.

Metformin is less effective in men with early-onset hair loss.

A rare genetic disease caused severe, worsening hair loss from early childhood with poor treatment results.

Long-term use of difluprednate eye drops in dogs can lead to hair loss and hormone imbalance.

Low HDL-C, uric acid, and 25-hydroxyvitamin D are risk factors for early-onset male hair loss.

People with androgenetic alopecia have different lipid levels in their blood, which vary between men and women, and may be linked to a higher risk of metabolic syndrome.

The document is a detailed guide on skin conditions and treatments for dermatologists.

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

Hormones significantly affect hair growth and loss, with potential for new treatments.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

People with androgenetic alopecia have a higher risk of heart disease.

Korean patients with PCOS often have skin problems like acne and excess hair, with different symptoms based on their specific PCOS type.

The document emphasizes the importance of correctly identifying and classifying genetic hair disorders to help diagnose related health conditions.

Skin aging reflects overall body aging and can indicate internal health conditions.

Ac-GFFY-IGF peptide is a promising, safe, and effective treatment for hair loss, better than current options.

Women with hair thinning have disrupted steroid hormone levels, but this doesn't often show as other health issues. More research is needed on hormone balance in this condition.

The treatment effectively promotes hair regrowth in androgenetic alopecia without causing skin irritation.

TRP channels in the skin are important for sensation and health, and targeting them could help treat skin disorders.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

K16 can partially replace K14 but causes hair loss and skin issues.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

New gene identification techniques have improved the understanding and classification of inherited hair disorders.

Patients with myotonic dystrophy often have skin problems that suggest early aging and vitamin D issues, and the severity of these problems is linked to their genetic condition and vitamin D levels.

Activating Tgr5 may help treat hair loss and bone loss.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

The document concludes that various childhood hair and nail disorders exist, some may improve on their own, and advances in genetics and immunology could enhance treatment and counseling.

Besnoitiosis, a parasitic disease, has been found in donkeys in Italy and may be more common in Europe than previously thought.

Altered hypothalamic activity may contribute to stress in alopecia areata patients.